Previous close | 4.97 |
Open | 5.05 |
Bid | 3.61 x 200 |
Ask | 5.05 x 100 |
Day's range | 4.85 - 5.07 |
52-week range | 2.13 - 7.37 |
Volume | |
Avg. volume | 66,657 |
Market cap | 329.119M |
Beta (5Y monthly) | 1.17 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
SOPHiA GENETICS ( NASDAQ:SOPH ) First Quarter 2024 Results Key Financial Results Revenue: US$15.8m (up 13% from 1Q...
The average of price targets set by Wall Street analysts indicates a potential upside of 65% in SOPHiA GENETICS (SOPH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...